Christopher E. Whitehead

1.4k total citations
25 papers, 461 citations indexed

About

Christopher E. Whitehead is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Christopher E. Whitehead has authored 25 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 4 papers in Organic Chemistry and 4 papers in Oncology. Recurrent topics in Christopher E. Whitehead's work include Melanoma and MAPK Pathways (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Glioma Diagnosis and Treatment (3 papers). Christopher E. Whitehead is often cited by papers focused on Melanoma and MAPK Pathways (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Glioma Diagnosis and Treatment (3 papers). Christopher E. Whitehead collaborates with scholars based in United States, Ukraine and United Kingdom. Christopher E. Whitehead's co-authors include Alnawaz Rehemtulla, M. Serghiou, Curt M. Breneman, Mukesh K. Nyati, Theodore S. Lawrence, Aarif Ahsan, Dipankar Ray, William B. Pratt, N. Sukumar and Susmita G. Ramanand and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Cancer Research.

In The Last Decade

Christopher E. Whitehead

25 papers receiving 459 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher E. Whitehead United States 10 291 112 77 54 42 25 461
Eun Jung Ko South Korea 13 261 0.9× 88 0.8× 210 2.7× 51 0.9× 20 0.5× 24 631
Andrew B. Benowitz United States 13 509 1.7× 207 1.8× 187 2.4× 83 1.5× 26 0.6× 22 714
John W. Rice United States 9 338 1.2× 37 0.3× 60 0.8× 17 0.3× 72 1.7× 12 473
Amy F. Barabasz United States 7 327 1.1× 36 0.3× 58 0.8× 17 0.3× 71 1.7× 8 442
Judith Nicholson United Kingdom 14 270 0.9× 117 1.0× 34 0.4× 28 0.5× 34 0.8× 24 523
Alexander Gozman United States 8 612 2.1× 120 1.1× 61 0.8× 27 0.5× 139 3.3× 22 778
J. Martin Herold United States 11 659 2.3× 62 0.6× 94 1.2× 70 1.3× 21 0.5× 18 830
David A. Ellis United States 16 207 0.7× 79 0.7× 146 1.9× 54 1.0× 26 0.6× 38 580
Weiwen Ying United States 16 658 2.3× 113 1.0× 188 2.4× 33 0.6× 59 1.4× 27 973
Stephanie Leimgruber United States 11 267 0.9× 84 0.8× 118 1.5× 111 2.1× 14 0.3× 16 499

Countries citing papers authored by Christopher E. Whitehead

Since Specialization
Citations

This map shows the geographic impact of Christopher E. Whitehead's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher E. Whitehead with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher E. Whitehead more than expected).

Fields of papers citing papers by Christopher E. Whitehead

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher E. Whitehead. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher E. Whitehead. The network helps show where Christopher E. Whitehead may publish in the future.

Co-authorship network of co-authors of Christopher E. Whitehead

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher E. Whitehead. A scholar is included among the top collaborators of Christopher E. Whitehead based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher E. Whitehead. Christopher E. Whitehead is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Whitehead, Christopher E., et al.. (2024). A first-in-class selective inhibitor of EGFR and PI3K offers a single-molecule approach to targeting adaptive resistance. Nature Cancer. 5(8). 1250–1266. 9 indexed citations
2.
Whitehead, Christopher E., Scott Kopetz, Veera Baladandayuthapani, et al.. (2024). Abstract 1230: MTX-531, a first-in-class pan-PI3K inhibitor spares hyperinsulinemia yielding durable tumor regressions and resilience to adaptive resistance. Cancer Research. 84(6_Supplement). 1230–1230. 1 indexed citations
3.
Sharma, Monika, Carlos E. Espinoza, Varunkumar Krishnamoorthy, et al.. (2023). Targeting DNA Repair and Survival Signaling in Diffuse Intrinsic Pontine Gliomas to Prevent Tumor Recurrence. Molecular Cancer Therapeutics. 23(1). 24–34. 4 indexed citations
4.
Whitehead, Christopher E., et al.. (2023). Special Considerations for Pediatric Burn Injuries. Physical Medicine and Rehabilitation Clinics of North America. 34(4). 825–837. 2 indexed citations
5.
Whitehead, Christopher E., et al.. (2022). Loss of NF1 in Melanoma Confers Sensitivity to SYK Kinase Inhibition. Cancer Research. 83(2). 316–331. 6 indexed citations
6.
7.
Whitehead, Christopher E., et al.. (2019). 319 Clinical Observations Using 3D Printed Hand and Finger Devices in Pediatric Burn Rehabilitation. Journal of Burn Care & Research. 40(Supplement_1). S137–S137. 1 indexed citations
8.
Whitehead, Christopher E., et al.. (2019). Dimensions of European Heritage and Memory: a Framework Introduction. 3 indexed citations
9.
10.
Dort, Marcian E. Van, Stefanie Galbán, Hanxiao Wang, et al.. (2015). Dual inhibition of allosteric mitogen-activated protein kinase (MEK) and phosphatidylinositol 3-kinase (PI3K) oncogenic targets with a bifunctional inhibitor. Bioorganic & Medicinal Chemistry. 23(7). 1386–1394. 44 indexed citations
11.
Shukla, Shirish, Uday Sankar Allam, Aarif Ahsan, et al.. (2014). KRAS Protein Stability Is Regulated through SMURF2: UBCH5 Complex-Mediated β-TrCP1 Degradation. Neoplasia. 16(2). 115–W5. 78 indexed citations
12.
Ahsan, Aarif, Susmita G. Ramanand, Ingrid L. Bergin, et al.. (2014). Efficacy of an EGFR-Specific Peptide against EGFR-Dependent Cancer Cell Lines and Tumor Xenografts. Neoplasia. 16(2). 105–W2. 28 indexed citations
13.
Ahsan, Aarif, Dipankar Ray, Susmita G. Ramanand, et al.. (2013). Destabilization of the Epidermal Growth Factor Receptor (EGFR) by a Peptide That Inhibits EGFR Binding to Heat Shock Protein 90 and Receptor Dimerization. Journal of Biological Chemistry. 288(37). 26879–26886. 29 indexed citations
14.
Rodrigueza, Wendi V., Christopher E. Whitehead, Ramzi M. Mohammad, et al.. (2012). Abstract 2764: Effect of PNT2258 combinations with docetaxel, dacarbazine, or vemurafenib on the A375 melanoma xenograft. Cancer Research. 72(8_Supplement). 2764–2764. 2 indexed citations
15.
Ahsan, Aarif, Susmita G. Ramanand, Christopher E. Whitehead, et al.. (2012). Wild-type EGFR Is Stabilized by Direct Interaction with HSP90 in Cancer Cells and Tumors. Neoplasia. 14(8). 670–IN1. 73 indexed citations
16.
Whitehead, Christopher E. & M. Serghiou. (2009). A 12-Year Comparison of Common Therapeutic Interventions in the Burn Unit. Journal of Burn Care & Research. 30(2). 281–287. 18 indexed citations
17.
Serghiou, M., et al.. (2009). Rehabilitation After a Burn Injury. Clinics in Plastic Surgery. 36(4). 675–686. 34 indexed citations
18.
Warmus, Joseph S., Cathlin Flamme, Stephen D. Barrett, et al.. (2008). 2-Alkylamino- and alkoxy-substituted 2-amino-1,3,4-oxadiazoles—O-Alkyl benzohydroxamate esters replacements retain the desired inhibition and selectivity against MEK (MAP ERK kinase). Bioorganic & Medicinal Chemistry Letters. 18(23). 6171–6174. 60 indexed citations
19.
Kaufman, Michael D., Stephen D. Barrett, Cathlin Flamme, et al.. (2004). Synthesis and SAR development of PD 0325901, a potent and highly bioavailable MEK inhibitor.. Cancer Research. 64. 573–573. 1 indexed citations
20.
Whitehead, Christopher E., Curt M. Breneman, N. Sukumar, & Margret Ryan. (2003). Transferable atom equivalent multicentered multipole expansion method. Journal of Computational Chemistry. 24(4). 512–529. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eun Jung Ko Breakdown of academic impact, for papers by Andrew B. Benowitz Breakdown of academic impact, for papers by John W. Rice Breakdown of academic impact, for papers by Amy F. Barabasz Breakdown of academic impact, for papers by Judith Nicholson Breakdown of academic impact, for papers by Alexander Gozman Breakdown of academic impact, for papers by J. Martin Herold Breakdown of academic impact, for papers by David A. Ellis Breakdown of academic impact, for papers by Weiwen Ying Breakdown of academic impact, for papers by Stephanie Leimgruber
Rankless by CCL
2026